1. Effects of Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in an Obese Rat Model
   Kiminori Watanabe et al, 2017, OBES SURG CrossRef
2. Bile acids at the cross-roads of gut microbiome–host cardiometabolic interactions
   Paul M. Ryan et al, 2017, Diabetol Metab Syndr CrossRef
3. Metabolomics-based evidence of the hypoglycemic effect of Ge-Gen-Jiao-Tai-Wan in type 2 diabetic rats via UHPLC-QTOF/MS analysis
   Wenbo Wang et al, 2018, Journal of Ethnopharmacology CrossRef
4. Chenodeoxycholic Acid Ameliorates AlCl3-Induced Alzheimer’s Disease Neurotoxicity and Cognitive Deterioration via Enhanced Insulin Signaling in Rats
   Firas H. Bazzari et al, 2019, Molecules CrossRef
5. Mechanistic evaluation of AMPK/SIRT1/FXR signaling axis, inflammation, and redox status in thioacetamide‐induced liver cirrhosis: The role of Cichorium intybus linn (chicory)‐supplemented diet
   Walaa A. Keshk et al, 2019, J Food Biochem CrossRef
6. Evidence for liver energy metabolism programming in offspring subjected to intrauterine undernutrition during midgestation
   Xiaoling Zhou et al, 2019, Nutr Metab (Lond) CrossRef
7. Gut microbiota: a promising target against cardiometabolic diseases
   Moritz V. Warmbrunn et al, 2020, Expert Review of Endocrinology & Metabolism CrossRef
8. Ganoderic acid A from Ganoderma lucidum ameliorates lipid metabolism and alters gut microbiota composition in hyperlipidemic mice fed a high-fat diet
   Wei-Ling Guo et al, 2020, Food Funct. CrossRef
9. Association of Serum Bile Acids Profile and Pathway Dysregulation With the Risk of Developing Diabetes Among Normoglycemic Chinese Adults: Findings From the 4C Study
   Jieli Lu et al, 2021, Dia Care CrossRef
10. Plant Compounds for the Treatment of Diabetes, a Metabolic Disorder: NF-κB as a Therapeutic Target
    Ravi Sahukari et al, 2020, CPD CrossRef
11. Serum Proteomic Analysis of Cannabis Use Disorder in Male Patients
    Fawaz Alasmari et al, 2021, Molecules CrossRef
12. Chains of evidence from correlations to causal molecules in microbiome-linked diseases
    Snehal N. Chaudhari et al, 2021, Nat Chem Biol CrossRef
13. Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4
    Wenyi Deng et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
14. Linking Nonalcoholic Fatty Liver Disease and Brain Disease: Focusing on Bile Acid Signaling
    Zi-Lin Ren et al, 2022, IJMS CrossRef
15. The Role of Bile Acids in Cardiovascular Diseases: from Mechanisms to Clinical Implications
    Shuwen Zhang et al, 2022, Aging and disease CrossRef
16. Effects of Resveratrol Supplementation and Exercise on Apoptosis, Lipid Profile, and Expression of Farnesoid X Receptor, Liver X Receptor and Sirtuin 1 Genes in the Liver of Type 1 Diabetic Rats
    Ali Nouri et al, 2022, mljgoums CrossRef
17. High-protein high-konjac glucomannan diets changed glucose and lipid metabolism by modulating colonic microflora and bile acid profiles in healthy mouse models
    Yetong Xu et al, 2024, Food Funct. CrossRef
18. Sex differences and testosterone interfere with the structure of the gut microbiota through the bile acid signaling pathway
    Xueqing Duan et al, 2024, Front. Microbiol. CrossRef
19. New Insights on the potential therapeutic effects of glibenclamide and Obeticholic acid against Alloxan-Induced diabetes mellitus in rat model
    Asmaa A. Aboushouk et al, 2024, International Immunopharmacology CrossRef
20. Chenodeoxycholic acid alleviated the cyclosporine-induced nephrotoxicity by decreasing oxidative stress and suppressing renin-angiotensin system through AT2R and ACE2 mRNA upregulation in rats
    İlknur Bingül et al, 2025, J Mol Histol CrossRef
21. Regulation of bile acids and their receptor FXR in metabolic diseases
    Yao Li et al, 2024, Front. Nutr. CrossRef